GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bittoo Kanwar, MD
Gilead Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Herston, Queensland, Australia
- Facility name not stated
San Juan, Puerto Rico
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Beverly Hills, California, United States
- Facility name not stated
Coronado, California, United States
- Facility name not stated
Costa Mesa, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Englewood, Colorado, United States
- Facility name not stated
Bradenton, Florida, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Burlington, Massachusetts, United States
- Facility name not stated
Kansas City, Missouri, United States
- Facility name not stated
Forest Hills, New York, United States
- Facility name not stated
Manhasset, New York, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
Arlington, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 3 Feb 2014
- Registered enrollment
- 351
- Registry id
- NCT01356160
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.